For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240118:nRSR2057Aa&default-theme=true
RNS Number : 2057A Deltex Medical Group PLC 18 January 2024
18 January 2024
Deltex Medical Group plc
("Deltex Medical", the "Company" or the "Group")
Issue of equity to satisfy equity-settled non-executive directors' fees
The Board of Deltex Medical (AIM: DEMG), announces the issue of 49,372,352 new
ordinary shares of 1p each in the capital of the Company (the "Ordinary
Shares"), at an issue price of 0.17 pence per new Ordinary Share (the "Issue
Price"). The Issue Price represents the Company's closing mid-market price on
17 January 2024.
The new Ordinary Shares are being issued in order to satisfy the fees of
certain current and former non-executive directors for the year ending 31
December 2023 ("Fee Shares"), as has been done in previous years.
A total of 12,941,176 Fee Shares will be issued to former non-executive
director Mark Wippell and a total of36,431,176 Fee Shares will be issued to
current non-executive directors as set out below:
Resultant holding post Fee Shares
Director Current Ordinary Shares held Fee Shares issued Ordinary Shares held As a percentage of the enlarged share capital on Admission
Nigel Keen 332,267,649 22,313,529 354,581,178 18.70%
Chris Jones 6,479,109 14,117,647 20,596,756 1.09%
Under the contract with Nigel Keen, he or the Company can opt to settle his
fees (plus employer's national insurance) by the issue of new ordinary shares
at the share price at the time of issue and the same applies to Chris Jones'
and Ben Carswell's contracts for up to half of their fees. These share issues
are expected to occur on an annual basis when permitted.
Application for admission to trading and total voting rights
Application has been made for 49,372,352 new Ordinary Shares to be admitted to
trading on AIM, which is expected to take effect on or around 24 January 2024
("Admission").
Following Admission, the Company's issued share capital will comprise
1,896,025,700 Ordinary Shares. The Company does not hold any Ordinary Shares
in treasury. This figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
For further information, please contact:
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman investorinfo@Deltexmedical.com (mailto:investorinfo@Fitbitmedical.com)
Andy Mears, Chief Executive
Natalie Wettler, Group Finance Director
Nominated Adviser and Broker 020 3328 5656
Allenby Capital Limited
Jeremy Porter / Vivek Bhardwaj (Corporate Finance) info@allenbycapital.com (mailto:info@allenbycapital.com)
Tony Quirke / Stefano Aquilino (Sales & Corporate Broking)
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name PDMRs:
Nigel Keen Non-Executive Director - Chairman
Chris Jones Non-Executive Director
2. Reason for the Notification
a) Position/status See 1a) above
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Deltex Medical Group Plc
b) LEI 213800XN34P6LI8J6M39
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of 0.1p each in Deltex Medical Group Plc
Identification code ISIN: GB0059337583
b) Nature of the transaction Fee shares
c) Price(s) and volume(s) Name Price(s) Volume(s)
Nigel Keen 0.17p 22,313,529
Chris Jones 0.17p 14,117,647
d) Aggregated information:
- Aggregated volume 36,431,176
- Price 0.17p
e) Date of the transaction 18 January 2024
f) Place of the transaction Outside a trading venue
2.
Reason for the Notification
a)
Position/status
See 1a) above
b)
Initial notification/Amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Deltex Medical Group Plc
b)
LEI
213800XN34P6LI8J6M39
4.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the Financial instrument, type of instrument
Ordinary shares of 0.1p each in Deltex Medical Group Plc
Identification code
ISIN: GB0059337583
b)
Nature of the transaction
Fee shares
c)
Price(s) and volume(s)
Name Price(s) Volume(s)
Nigel Keen 0.17p 22,313,529
Chris Jones 0.17p 14,117,647
d)
Aggregated information:
- Aggregated volume
36,431,176
- Price
0.17p
e)
Date of the transaction
18 January 2024
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOESFUFMAELSEIF